Type 2 diabetes mellitus management in Canada: is it improving?

OBJECTIVE To gain insight into the current management of patients with type 2 diabetes mellitus by Canadian primary care physicians. METHOD A total of 479 primary care physicians from across Canada submitted data on 5123 type 2 diabetes patients whom they had seen on a single day on or around World Diabetes Day, November 14, 2012. RESULTS Mean glycated hemoglobin (A1C) was 7.4%, low-density lipoprotein (LDL-C) was 2.1 mmol/L and blood pressure (BP) was 128/75 mm Hg. A1C ≤7.0% was met by 50%, LDL-C ≤2.0 mmol/L by 57%, BP <130/80 mm Hg by 36% and the composite triple target by 13% of patients. Diet counselling had been offered to 38% of patients. Of the 87% prescribed antihyperglycemic agents, 18% were on 1 non-insulin antihyperglycemic agent (NIAHA) (85% of which was metformin), 15% were on 2 NIAHAs, 6% were on ≥3 NIAHAs, 19% were on insulin only and 42% were on insulin + ≥1 NIAHA(s). Amongst the 81% prescribed lipid-lowering therapy, 88% were on monotherapy (97% of which was a statin). Among the 83% prescribed antihypertensive agents, 39%, 34%, 21% and 6% received 1, 2, 3 and >3 drugs, respectively, with 59% prescribed angiotensin-converting enzyme inhibitors and 35% angiotensin II receptor blockers. CONCLUSIONS The Diabetes Mellitus Status in Canada survey highlights the persistent treatment gap associated with the treatment of type 2 diabetes and the challenges faced by primary care physicians to gain glycemic control and global vascular protection in these patients. It also reveals a higher use of insulin therapy in primary care practices relative to previous surveys. Practical strategies aimed at more effectively managing type 2 diabetes patients are urgently needed.

[1]  G. Francis,et al.  Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS). , 2010, The Canadian journal of cardiology.

[2]  R. Holman,et al.  10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.

[3]  G. Fodor,et al.  Results of the Ontario Survey on the Prevalence and Control of Hypertension , 2008, Canadian Medical Association Journal.

[4]  S. Inzucchi,et al.  Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) , 2013, Diabetologia.

[5]  B. Bolinder,et al.  Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002. , 2006, Clinical therapeutics.

[6]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[7]  J. Chan,et al.  Multifaceted Determinants for Achieving Glycemic Control , 2009, Diabetes Care.

[8]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[9]  N. Xu,et al.  The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China. , 2010, Clinical therapeutics.

[10]  Lawrence A Leiter,et al.  AUDIT study. Evidence of global undertreatment of dyslipidaemia in patients with type 2 diabetes mellitus , 2006 .

[11]  R. McPherson,et al.  Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[12]  Lawrence A Leiter,et al.  Poor achievement of guidelines‐recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study , 2012, International journal of clinical practice.

[13]  R. McPherson,et al.  Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. , 2006, The Canadian journal of cardiology.

[14]  Valérie Santschi,et al.  Pharmacist Interventions to Improve Cardiovascular Disease Risk Factors in Diabetes , 2012, Diabetes Care.

[15]  R. Holman,et al.  Ten-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes , 2009 .

[16]  P. Lindsay,et al.  Canadian Hypertension Education Program: the science supporting New 2011 CHEP recommendations with an emphasis on health advocacy and knowledge translation. , 2011, The Canadian journal of cardiology.

[17]  D. Aron,et al.  Nurse practitioner‐led multidisciplinary teams to improve chronic illness care: The unique strengths of nurse practitioners applied to shared medical appointments/group visits , 2009, Journal of the American Academy of Nurse Practitioners.

[18]  D. Gaudet,et al.  Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO). , 2005, The Canadian journal of cardiology.

[19]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes , 2004 .

[20]  Irl B Hirsch,et al.  American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[21]  Robert Dufour,et al.  Canadian Cardiovascular Society / Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations , 2009 .

[22]  Irl B Hirsch,et al.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[23]  R. Tsuyuki,et al.  Glycemic Control in Community-Dwelling Patients with Type 2 Diabetes , 2012, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

[24]  S. Harris,et al.  Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). , 2005, Diabetes research and clinical practice.

[25]  P. Sham,et al.  Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. , 2009, The American journal of medicine.

[26]  André Scheen,et al.  RECOMMANDATIONS 2012 EN DIABÉTOLOGIE: Prise en charge de l'hyperglycémie dans le diabète de type 2: une approche centrée sur le patient , 2012 .

[27]  Belgium.,et al.  Global guideline for type 2 diabetes. , 2014, Diabetes research and clinical practice.

[28]  G. Booth,et al.  Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Methods. , 2013, Canadian journal of diabetes.

[29]  F. McAlister,et al.  Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis , 2004, Canadian Medical Association Journal.